EXE.TO Extendicare Inc.

Extendicare Announces Timing of 2024 Fourth Quarter Results and Conference Call

Extendicare Announces Timing of 2024 Fourth Quarter Results and Conference Call

MARKHAM, Ontario, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it plans to release its financial results for the fourth quarter of 2024 after market close on Thursday, February 27, 2025. A conference call hosted by Michael Guerriere, President and Chief Executive Officer, and David Bacon, Senior Vice President and Chief Financial Officer, will be held on Friday, February 28, 2025, at 11:30 a.m. (ET) to discuss the results.

To participate in the conference call on February 28, 2025, please dial 1-844-763-8274. A replay of the call by phone will be available approximately two hours after completion of the live call until midnight on March 14, 2025, by dialing 1-855-669-9658 followed by the passcode 5947943#.

A live webcast of the conference call and accompanying slide presentation will be available for those not participating in the call at under the “Our Investors/Events & Presentations” section and will be followed by an archived recording.

About Extendicare

Extendicare is a leading provider of care and services for seniors across Canada, operating under the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. We are committed to delivering quality care to meet the needs of a growing seniors’ population, inspired by our mission to provide people with the care they need, wherever they call home. We operate a network of 122 long-term care homes (52 owned/70 under management contracts), deliver approximately 10.7 million hours of home health care services annually, and provide group purchasing services to third parties representing approximately 143,500 beds across Canada. Extendicare proudly employs approximately 22,000 qualified, highly trained and dedicated team members who are passionate about providing high-quality care and services to help people live better.

Extendicare contact:

Jillian Fountain

Vice President, Investor Relations

T: (905) 470-5534

E:



EN
13/01/2025

Underlying

EXE.TOExtendicare Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Extendicare Inc.

Free Trial
EXE.TO Extendicare Inc...

Extendicare Inc: 1 director

A director at Extendicare Inc sold 124,200 shares at 13.097CAD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...

EXE.TO EXTENDICARE INC.
03/22/25 March 22, 2025 1 EN
 PRESS RELEASE
Free
EXE.TO Extendicare Inc...

Extendicare Announces March 2025 Dividend of C$0.042 per Share

Extendicare Announces March 2025 Dividend of C$0.042 per Share MARKHAM, Ontario, March 17, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.042 per common share of the Company (the “Common Share”) for the month of March 2025, which is payable on April 15, 2025 to shareholders of record at the close of business on March 31, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). About Extendicare Extendicare is a leading provider of care and s...

March 17, 2025 1 EN
 PRESS RELEASE
Free
EXE.TO Extendicare Inc...

Extendicare Announces 2024 Fourth Quarter and Full Year Results and Di...

Extendicare Announces 2024 Fourth Quarter and Full Year Results and Dividend Increase MARKHAM, Ontario, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three and twelve months ended December 31, 2024. Fourth Quarter 2024 Highlights Adjusted EBITDA(1) excluding out-of-period items increased by $10.1 million or 43.5% to $33.4 million driven by improvements in all three business segments.Home health care average daily volume (“ADV”) increased to 30,993, an increase of 10.1% from Q4 2023.SGP third-part...

February 27, 2025 1 EN
 PRESS RELEASE
Free
EXE.TO Extendicare Inc...

Extendicare Announces Changes to Board of Directors

Extendicare Announces Changes to Board of Directors MARKHAM, Ontario, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today announced the appointment of Donald Clow and Heather-Anne Irwin to its board of directors for a term to expire at the next annual meeting of shareholders, whereupon Mr. Clow and Ms. Irwin will stand for election. Concurrent with these appointments, the Company also announced the retirement of Al Mawani from the board of directors after seven years of service. In his time on the board, Mr. Mawani served as a member of var...

February 27, 2025 1 EN
 PRESS RELEASE
Free
EXE.TO Extendicare Inc...

Extendicare Announces February 2025 Dividend of C$0.04 per Share

Extendicare Announces February 2025 Dividend of C$0.04 per Share MARKHAM, Ontario, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common Share”) for the month of February 2025, which is payable on March 17, 2025 to shareholders of record at the close of business on February 28, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). About Extendicare Extendicare is a leading provider of care...

February 14, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch